Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

NCT00764634 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Botulism Vaccine

Interventions

BIOLOGICAL: Placebo (USP sterile saline for injection)
BIOLOGICAL: rBV A/B-40 vaccine
BIOLOGICAL: Placebo (USP sterile saline for injection)
BIOLOGICAL: rBV A/B-40 vaccine

Sponsor

DynPort Vaccine Company LLC, A GDIT Company